By contrast, both T cells redirected by a TDB and chimeric antigen receptor (CAR)-T cells, which are genetically engineered redirected T cells with an antibody-based CAR, can attack tumor cells independent of MHC engagement [10, 22–24]. Here, HLA-C is linked to neoplasm.